ReviewTargeted oncology2025

Olaparib Monotherapy or in Combination with Abiraterone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and a BRCA Mutation.

Fred Saad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.